HER2 Positive Gastric Cancer Market is expected to be valued at USD 1779.8 million by 2033, at a CAGR of 3.5%
The global HER2 Positive Gastric Cancer Market is currently valued at USD 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach USD 1779.8 million by 2033.
“Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 positive market during the forecast period.”
https://www.futuremarketinsigh....ts.com/reports/her2-
